DK0780390T3 - Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne - Google Patents
Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denneInfo
- Publication number
- DK0780390T3 DK0780390T3 DK96119134T DK96119134T DK0780390T3 DK 0780390 T3 DK0780390 T3 DK 0780390T3 DK 96119134 T DK96119134 T DK 96119134T DK 96119134 T DK96119134 T DK 96119134T DK 0780390 T3 DK0780390 T3 DK 0780390T3
- Authority
- DK
- Denmark
- Prior art keywords
- cdch
- preparation
- pharmaceutical compositions
- compositions containing
- crystal modification
- Prior art date
Links
- 102100034741 Cyclin-dependent kinase 20 Human genes 0.000 title 1
- 101500014379 Lymnaea stagnalis Ovulation hormone Proteins 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19546249A DE19546249A1 (de) | 1995-12-12 | 1995-12-12 | Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0780390T3 true DK0780390T3 (da) | 2002-11-11 |
Family
ID=7779831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96119134T DK0780390T3 (da) | 1995-12-12 | 1996-11-29 | Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne |
Country Status (42)
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895233A (zh) * | 1997-09-25 | 2007-01-17 | 拜尔公司 | 控释活性化合物的药物制剂 |
| DE19751948A1 (de) | 1997-11-24 | 1999-05-27 | Bayer Ag | Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren |
| US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| US6716830B2 (en) | 1998-09-30 | 2004-04-06 | Alcon, Inc. | Ophthalmic antibiotic compositions containing moxifloxacin |
| US6509327B1 (en) | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
| DE59910858D1 (de) * | 1998-11-10 | 2004-11-18 | Bayer Healthcare Ag | Pharmazeutische zubereitung von moxifloxacin |
| DE19854355A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE19854356A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE19908449A1 (de) * | 1999-02-26 | 2000-08-31 | Bayer Ag | Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure |
| AU2003278418A1 (en) * | 2002-10-31 | 2004-05-25 | Ranbaxy Laboratories Limited | Amorphous moxifloxacin hydrochloride |
| WO2004091619A1 (en) * | 2003-04-09 | 2004-10-28 | Dr. Reddy's Laboratories Limited | A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof |
| EP1651630A1 (en) * | 2003-08-05 | 2006-05-03 | Matrix Laboratories Ltd | An improved process for the preparation of moxifloxacin hydrochloride |
| WO2005054240A1 (en) * | 2003-11-20 | 2005-06-16 | Chemi Spa | Polymorphs of 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof |
| ITMI20032259A1 (it) | 2003-11-20 | 2005-05-21 | Chemi Spa | Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione |
| US7491725B2 (en) | 2004-02-06 | 2009-02-17 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| DE102004015981A1 (de) * | 2004-04-01 | 2005-10-20 | Bayer Healthcare Ag | Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE102004063347A1 (de) * | 2004-12-23 | 2006-07-13 | Stada Arzneimittel Ag | Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate |
| WO2007033515A1 (fr) * | 2005-09-21 | 2007-03-29 | Shenzhen Tys R & D Co., Ltd. | Formulation orale contenant de la moxifloxacine et son procédé de préparation |
| GB0612422D0 (en) * | 2006-06-23 | 2006-08-02 | Generics Uk Ltd | Novel hydrate form |
| SI2032521T1 (sl) | 2006-06-27 | 2010-02-26 | Sandoz Ag | Nov postopek za pripravo soli |
| ES2303768B1 (es) * | 2006-09-08 | 2009-06-05 | Quimica Sintetica, S.A. | Nueva forma cristalina de moxifloxacino clorhidrato. |
| WO2008059223A2 (en) * | 2006-11-13 | 2008-05-22 | Cipla Limited | Process for the synthesis of moxifloxacin hydrochloride |
| EP1992626A1 (en) * | 2007-05-10 | 2008-11-19 | Sandoz AG | Process for the preparation of moxifloxacin hydrochloride |
| EP2083010A1 (en) * | 2008-01-08 | 2009-07-29 | Chemo Ibérica, S.A. | Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof |
| EP2154137A1 (en) | 2008-08-04 | 2010-02-17 | Chemo Ibérica, S.A. | Crystalline form of moxifloxacin base |
| WO2010041100A1 (en) * | 2008-10-09 | 2010-04-15 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Using of organic solvents in wet granulation of moxifloxacin |
| US20110212990A1 (en) * | 2008-11-06 | 2011-09-01 | Hetero Research Foundation | Novel polymorph of moxifloxacin hydrochloride |
| EP2364141B2 (de) | 2008-12-08 | 2017-08-02 | ratiopharm GmbH | Kompaktiertes moxifloxacin |
| NZ596492A (en) | 2009-05-15 | 2013-08-30 | Redx Pharma Ltd | Redox drug derivatives |
| WO2011121596A2 (en) * | 2010-04-01 | 2011-10-06 | Neuland Laboratories Ltd. | Crystal modification of moxifloxacin hydrochloride |
| BRPI1106900A2 (pt) | 2011-12-26 | 2013-11-05 | Ems Sa | Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção |
| FR2992218B1 (fr) | 2012-06-22 | 2015-01-23 | Rivopharm Sa | Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation |
| CN102924449B (zh) * | 2012-10-30 | 2015-08-12 | 重庆福安药业集团庆余堂制药有限公司 | 盐酸莫西沙星h晶型及其制备方法和药物组合物 |
| WO2014087292A1 (en) | 2012-12-04 | 2014-06-12 | Mankind Research Centre | An improved process for the preparation of moxifloxacin hydrochloride |
| RU2561037C2 (ru) * | 2013-02-07 | 2015-08-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Антибактериальная фармацевтическая композиция и способ ее получения |
| US12036219B2 (en) | 2013-03-15 | 2024-07-16 | Melinta Subsidiary Corp. | Methods of treating infections in overweight and obese patients using antibiotics |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3601567A1 (de) * | 1986-01-21 | 1987-07-23 | Bayer Ag | 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate |
| NO871333L (no) * | 1986-03-31 | 1987-10-01 | Sankyo Co | Kinolin-3-karboksylsyrederivater, fremgangsmaate til fremstilling og anvendelse derav. |
| AU609974B2 (en) * | 1988-05-18 | 1991-05-09 | Warner-Lambert Company | Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| RO108347B1 (ro) * | 1989-10-30 | 1994-04-28 | Bellon Labor Sa Roger | DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA |
| TW209865B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-01-10 | 1993-07-21 | Bayer Ag | |
| ES2167329T3 (es) * | 1992-01-31 | 2002-05-16 | Chugai Pharmaceutical Co Ltd | Cristal de hidrato de derivado de acido quinolonacarboxilico. |
| DE4234078A1 (de) * | 1992-10-09 | 1994-04-14 | Bayer Ag | Chinoloncarbonsäuren |
| JP3268098B2 (ja) * | 1992-12-25 | 2002-03-25 | 第一製薬株式会社 | 二環性環状アミン誘導体 |
| ZA946853B (en) * | 1993-09-10 | 1995-04-24 | Daiichi Seiyaku Co | Crystals of antimicrobial compound. |
| ES2121293T3 (es) * | 1994-04-07 | 1998-11-16 | Pfizer | Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori. |
-
1995
- 1995-12-12 DE DE19546249A patent/DE19546249A1/de not_active Withdrawn
-
1996
- 1996-11-22 MA MA24398A patent/MA24342A1/fr unknown
- 1996-11-25 HR HR960558A patent/HRP960558B1/xx not_active IP Right Cessation
- 1996-11-25 RO RO96-02223A patent/RO119782B1/ro unknown
- 1996-11-27 CU CU1996111A patent/CU22774A3/es not_active IP Right Cessation
- 1996-11-29 AT AT96119134T patent/ATE221531T1/de active
- 1996-11-29 EP EP96119134A patent/EP0780390B1/de not_active Expired - Lifetime
- 1996-11-29 DK DK96119134T patent/DK0780390T3/da active
- 1996-11-29 ES ES96119134T patent/ES2179910T3/es not_active Expired - Lifetime
- 1996-11-29 DE DE59609501T patent/DE59609501D1/de not_active Expired - Lifetime
- 1996-11-29 SI SI9630468T patent/SI0780390T1/xx unknown
- 1996-11-29 PT PT96119134T patent/PT780390E/pt unknown
- 1996-12-05 US US08/760,543 patent/US5849752A/en not_active Expired - Lifetime
- 1996-12-05 TR TR96/00970A patent/TR199600970A2/xx unknown
- 1996-12-06 YU YU65096A patent/YU49485B/sh unknown
- 1996-12-06 IN IN2723DE1996 patent/IN185805B/en unknown
- 1996-12-06 TW TW085115048A patent/TW411340B/zh not_active IP Right Cessation
- 1996-12-06 AU AU74216/96A patent/AU708006B2/en not_active Expired
- 1996-12-09 NZ NZ299905A patent/NZ299905A/en not_active IP Right Cessation
- 1996-12-09 CA CA002192418A patent/CA2192418C/en not_active Expired - Lifetime
- 1996-12-09 AR ARP960105569A patent/AR005009A1/es active IP Right Grant
- 1996-12-10 BG BG101043A patent/BG62258B1/bg unknown
- 1996-12-10 CO CO96064770A patent/CO4480105A1/es unknown
- 1996-12-10 PL PL96317415A patent/PL184885B1/pl unknown
- 1996-12-10 ID IDP963684A patent/ID22625A/id unknown
- 1996-12-10 JP JP34450296A patent/JP4104687B2/ja not_active Expired - Lifetime
- 1996-12-10 IL IL11979596A patent/IL119795A/en not_active IP Right Cessation
- 1996-12-10 SG SG1996011612A patent/SG47201A1/en unknown
- 1996-12-11 SK SK1591-96A patent/SK282805B6/sk not_active IP Right Cessation
- 1996-12-11 ZA ZA9610405A patent/ZA9610405B/xx unknown
- 1996-12-11 MY MYPI96005214A patent/MY117492A/en unknown
- 1996-12-11 BR BR9605968A patent/BR9605968A/pt not_active IP Right Cessation
- 1996-12-11 UA UA96124628A patent/UA35638C2/uk unknown
- 1996-12-11 RU RU96123410/04A patent/RU2162468C2/ru active
- 1996-12-11 KR KR1019960064345A patent/KR100525146B1/ko not_active Expired - Lifetime
- 1996-12-11 EE EE9600201A patent/EE03474B1/xx unknown
- 1996-12-11 CZ CZ19963646A patent/CZ288657B6/cs not_active IP Right Cessation
- 1996-12-11 NO NO19965298A patent/NO306725B1/no not_active IP Right Cessation
- 1996-12-11 SA SA96170492A patent/SA96170492B1/ar unknown
- 1996-12-12 CN CN96123220A patent/CN1061348C/zh not_active Expired - Lifetime
- 1996-12-12 SV SV1996000109A patent/SV1996000109A/es active IP Right Grant
- 1996-12-12 HU HU9603428A patent/HU226521B1/hu unknown
-
2002
- 2002-12-05 NL NL300109C patent/NL300109I1/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0780390T3 (da) | Krystalmodifikation af CDCH, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende denne | |
| DK1156049T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK0861089T3 (da) | Metoder og sammensætninger til indgivelse af monomere proteiner | |
| DK0807086T3 (da) | Fremgangsmåde til fremstilling af hydrotalciter | |
| DK0817780T3 (da) | Taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser | |
| NO964700D0 (no) | Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser | |
| DK0496386T4 (da) | Katalysatorbærer samt sammensætning og fremgangsmåde til fremstilling af denne | |
| DK0612741T3 (da) | Cykliske derivater, lægemidler indeholdende disse forbindelser og fremgangsmåde til deres fremstilling | |
| DK0812195T3 (da) | Farmaceutisk sammensætning til piperidinoalkanolforbindelser | |
| DK0885204T3 (da) | Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser | |
| DK0719775T3 (da) | Substituerede derivater af 4-phenylthiazol, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, der inde | |
| DK0839138T3 (da) | Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler | |
| DK0768310T3 (da) | Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater | |
| DK0735042T3 (da) | Maltitolsammensætning og fremgangsmåde til fremstilling deraf | |
| DK0805797T3 (da) | Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer | |
| DK0877738T3 (da) | Fremgangsmåde til fremstilling af phenylimidazolidinderivater | |
| DK102990A (da) | Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
| DK0583338T3 (da) | Fremgangsmåde til syntese af peptider, hidtil ukendte aminosyrederivater anvendt i denne fremgangsmåde og fremgangsmåder til deres fremstilling | |
| DK1031565T3 (da) | Hidtil ukendte krystaller af depsipeptidderivat og fremgangsmåde til fremstilling heraf | |
| DK187989D0 (da) | Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser | |
| DK0727417T3 (da) | Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og anvendelse af farmaceutiske præparater på grundlag af disse forbindelser samt lægemidler, der indeholder dem | |
| FI944751L (fi) | Heteroaryylipiperidiinejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
| DK0998470T3 (da) | Fremgangsmåde til fremstilling af aminderivater af alkyloxyfuranon, forbindelser fremstillet ved denne fremgangsmåde og anvendelse af disse forbindelser | |
| FI960284L (fi) | Uudet merkaptoalkanoyylidipeptidiyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| DK0824515T3 (da) | Substitueret phenylamidiner, medikamenter indeholdende disse forbindelser og fremgangsmåder til fremstilling deraf |